Skip to main content

ORIGINAL RESEARCH article

Front. Neuroimaging
Sec. Clinical Neuroimaging
Volume 3 - 2024 | doi: 10.3389/fnimg.2024.1410848
This article is part of the Research Topic Role of Neuroimaging in the Diagnosis and Treatment of Rare Diseases View all 3 articles

Quantitative reliability assessment of brain MRI volumetric measurements in type II GM1 gangliosidosis patients

Provisionally accepted
Christopher Zoppo Christopher Zoppo 1Josephine Kolstad Josephine Kolstad 1Jean Johnston Jean Johnston 2Precilla D. Souza Precilla D. Souza 2Anna L. Kühn Anna L. Kühn 1Zeynep Vardar Zeynep Vardar 1Ahmet Peker Ahmet Peker 3Clifford Lindsay Clifford Lindsay 1Zubir S. Rentiya Zubir S. Rentiya 4Robert King Robert King 1Heather Gray-Edwards Heather Gray-Edwards 1Behroze Vachha Behroze Vachha 1Maria T. Acosta Maria T. Acosta 2Cynthia Tifft Cynthia Tifft 2Mohammed Salman Shazeeb Mohammed Salman Shazeeb 1*
  • 1 University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States
  • 2 National Institutes of Health (NIH), Bethesda, Maryland, United States
  • 3 Koç University Hospital, Istanbul, Türkiye
  • 4 University of Virginia, Charlottesville, Virginia, United States

The final, formatted version of the article will be published soon.

    GM1-gangliosidosis (GM1) leads to extensive neurodegenerative changes and atrophy that precludes the use of automated MRI segmentation techniques for generating brain volumetrics. We developed a standardized segmentation protocol for brain MRIs of patients with type II GM1 and then assessed the inter-and intra-rater reliability of this methodology. The volumetric data may be used as a biomarker of disease burden and progression, and standardized methodology may support research into the natural history of the disease which is currently lacking in the literature. Approach Twenty-five brain MRIs were included in this study from 22 type II GM1 patients of which 8 were late-infantile subtype and 14 were juvenile subtype. The following structures were segmented by two rating teams on a slice-by-slice basis: whole brain, ventricles, cerebellum, lentiform nucleus, thalamus, corpus callosum, and caudate nucleus. The inter-and intra-rater reliability of the segmentation method was assessed with an intraclass correlation coefficient as well as Sorensen-Dice and Jaccard coefficients.Based on the Sorensen-Dice and Jaccard coefficients, the inter-and intra-rater reliability of the segmentation method was significantly better for the juvenile patients compared to late-infantile (p < 0.01). In addition, the agreement between the two rater teams and within themselves can be considered good with all p-values < 0.05.The standardized segmentation approach described here has good inter-and intra-rater reliability and may provide greater accuracy and reproducibility for neuromorphological studies in this group of patients and help to further expand our understanding of the natural history of this disease.

    Keywords: GM1 Gangliosidosis, inter/intra-rater reliability, brain MRI, volumetrics, segmentation

    Received: 01 Apr 2024; Accepted: 22 Aug 2024.

    Copyright: © 2024 Zoppo, Kolstad, Johnston, Souza, Kühn, Vardar, Peker, Lindsay, Rentiya, King, Gray-Edwards, Vachha, Acosta, Tifft and Shazeeb. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Mohammed Salman Shazeeb, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.